Morgan Stanley raised the firm’s price target on Bowhead Specialty (BOW) to $27 from $25 and keeps an Equal Weight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty Earnings Call Highlights Profitable Growth
- Bowhead Specialty Reports Strong First-Quarter 2026 Financial Results
- Bowhead Specialty reports Q1 adjusted EPS 48c, consensus 41c
- Bowhead Specialty price target lowered to $35 from $38 at Citizens
- Bowhead Specialty price target lowered to $31 from $36 at Keefe Bruyette